Delivery Order SPE2DB20D3303-SPE2DB24FA0AM
Award Date 6/13/24
Potential Completion Date 6/14/24
Potential Value $2.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation. The $2,894.95 contract is for the delivery of the pharmaceutical product Orilissa 150 mg tablets. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31,...
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order (SPE2DB20D2001|SPE2DB23FM70E) valued at $13,309.86 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug Orilissa 150 mg tablets with an ultimate completion date of August 25, 2023. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products and medical supplies. The contract, valued at $9,761.70, is a Firm Fixed Price Delivery Order with an ultimate completion date of December 27, 2024. The award is for the delivery of the drug Orilissa 200 mg Tablet 14s, a medication used for the treatment of endometriosis. The contract does not have a set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,406.31 firm fixed-price delivery order is for the supply of the prescription medication Orilissa 200 mg tablets. The contract has an ultimate completion date of August 13, 2024. While no set-aside designation is mentioned, Amerisourcebergen holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a...
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (SPE2DB23FU13P) under an Indefinite Delivery Contract (SPE2DB20D2104) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Orilissa 200 mg tablets, a pharmaceutical product used for various medical treatments. The total ceiling value of this specific delivery order is $2,910.29, with a firm fixed price pricing type. The contract does not have a set-aside designation,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $2,821.04 firm fixed-price delivery order is for the supply of ORILISSA 150 MG TABLET 7S, a prescription medication. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of...
- This federal contract award to AmerisourceBergen Drug Corp, a pharmaceutical distributor, is a delivery order valued at $19,371.14 for the supply of the medication Orilissa 150 mg tablet. The award was made by the Defense Logistics Agency (DLA), a defense agency, and it has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management (SAM.gov). The contract is...
- This is a delivery order (SPE2DB22D2007|SPE2DB24FJ0FZ) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,361.44, is for the delivery of the drug Orilissa 150 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999 and running through November 2026. The IDC...
- This federal contract award is for the delivery of pharmaceutical products, specifically the drug Orilissa, to support the healthcare needs of the U.S. military and federal government. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,425.49 and was awarded on November 9, 2021, with a completion date of November 10, 2021. It is a firm-fixed-price delivery order contract awarded by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $2,249.40, is a Firm Fixed Price Delivery Order for the pharmaceutical product ORILISSA 150 MG TABLET 7S. The contract has an ultimate completion date of July 26, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare...